Lv1
48 积分 2026-02-03 加入
Late toxicities and surveillance strategies after anti-CD19 and anti-BCMA CAR-T cell therapy
3个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
3个月前
已完结
B cells as target for immunotherapy in rheumatic diseases – current status
5个月前
已完结
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
6个月前
已完结
Treatment of two pediatric patients with refractory systemic lupus erythematosus using CD19-targeted CAR T-cells
7个月前
已完结
皖公网安备34019202002308
